Noninvasive Sepsis Monitor Patent Filed by Zynex Can Provides Caregivers with Advanced Warning or Prediction of the Onset of Sepsis

Sepsis is one of the biggest problems in hospitals today. In the U.S. alone, over 1.7 million adults will develop sepsis annually with nearly 270,000 deaths as a result.

Zynex Receives FDA Clearance for its Blood Volume Monitor

Blood Volume Monitor is fully developed, has performed well in multiple clinical trials and can guide medical professionals in hospitals and surgical centers towards better fluid management during surgery and in recovery settings.

Zynex Obtains European Patent Blood Volume Monitor Device

Thomas Sandgaard, the inventor, has assigned the patent to Zynex's subsidiary, Zynex Monitoring Solutions.